Huge retroperitoneal liposarcoma: one case report and literature review

doi:10.3877/cma.j.issn.1674-3253.2019.04.016

Abstract

Abstract:

Objective

To explore the multi-disciplinary team (MDT) for patients with peritoneal tumor recurrence after surgical resection of retroperitoneal giant liposarcoma.

Methods

Clinical data of a 45-year-old male patient with peritoneal tumor recurrence approximately 10 cm×9 cm in size after surgical resection of retroperitoneal giant liposarcoma were retrospectively analyzed. The procedures of two cycles of diagnoses and treatments and MDT highlights were reviewed. Relevant literatures at home and abroad were summarized.

Results

The patient underwent open resection of multiple abdominal tumors + cholecystectomy + omentectomy to successfully resect the tumors. Postoperative pathological examination confirmed the diagnosis of dedifferentiated lipoblastoma. The patient was recovered and discharged after treatment. At postoperative 45 d, the patient recurred and continued to be treated with targeted drugs (Apatinib at 500 mg qd).

Conclusion

It is difficult to deliver early diagnosis of retroperitoneal liposarcoma and perform the operation. MDT combined with imaging examination and clinicopathological features can make an accurate diagnosis. Comprehensive evaluation of early surgery can achieve certain clinical efficacy, whereas the overall prognosis of patients with dedifferentiated liposarcoma is poor.

Key words: Liposarcoma, Abdominal mass, Surgery, Etroperitoneal, MDT

Jiankun Zheng, Zhansen Huang, Dejuan Wang, Wentao Huang, Ke Li, Cheng Hu, Jianguang Qiu. Huge retroperitoneal liposarcoma: one case report and literature review[J]. Chinese Journal of Endourology(Electronic Edition), 2019, 13(04): 280-284.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhqjmnmwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3253.2019.04.016

https://zhqjmnmwkzz.cma-cmc.com.cn/EN/Y2019/V13/I04/280

Figures/Tables 2

References 21

[1]	Pasquali S, Gronchi A. Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications[J]. Ther Adv Med Oncol, 2017, 9 (6): 415-429.
[2]	Anaya DA1, Lahat G, Liu J, et al. Pollock Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making[J]. Ann Surg, 2009, 249 (1): 137-142.
[3]	Bonvalot S, Rivoire M, Castaing M, et al. Laplanche Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control[J]. J Clin Oncol, 2009, 27(1): 31-37.
[4]	Ballo MT, Zagars GK, Pollock RE, et al. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment[J]. Int J Radiat Oncol Biol Phys, 2007, 67(1): 158-163.
[5]	Choi AH, Barnholtz-Sloan JS, Kim JA. Kim Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis[J]. Ann Oncol, 2012, 23(9): 2449-2457.
[6]	Puzio-Kuter AM, Laddha SV, Castillo-Martin M, et al. Involvement of tumor suppressors PTEN and p 53 in the formation of multiple subtypes of liposarcoma[J]. Cell Death Differ, 2015, 22(11): 1785-1791.
[7]	Samuels BL, Chawla SP, Somaiah N, et al. Stepanski Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma[J]. Cancer, 2017, 123(23): 4640-4647.
[8]	Erzen D, Sencar M, Novak J. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology Ljubljana[J]. J Surg Oncol, 2005, 91(1): 1-9.
[9]	Henricks WH, Chu YC, Goldblum JR, et al. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation[J]. Am J Surg Pathol, 1997, 21(3): 271-281.
[10]	Gronchi A, Ferrari S, Quagliuolo V, et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial[J]. Lancet Oncol, 2017, 18 (6): 812-822.
[11]	Gunderson LL, Shipley WU, Suit HD, et al. Intraoperative irradiation: a pilot study combining external beam photons with "boost" dose intraoperative electrons[J]. Cancer 1982, 49 (11): 2259-2266.
[12]	Mariani O, Brennetot C, Coindre JM, et al. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas[J]. Cancer Cell, 2007, 11 (4): 361-374.
[13]	Tuan J, Vitolo V, Vischioni B, et al. Radiation therapy for retroperitoneal sarcoma[J]. Radiol Med, 2014, 119 (10): 790-802.
[14]	Ecker BL, Peters MG1, McMillan MT, et al. Preoperative radiotherapy in the management of retroperitoneal liposarcoma[J]. Br J Surg, 2016, 103 (13): 1839-1846.
[15]	Marinello P, Montresor E, Iacono C, et al. Long-term results of aggressive surgical treatment of primary and recurrent retroperitoneal liposarcomas[J]. Chir Ital, 2001, 53 (2): 149-157.
[16]	Demetri GD, Chawla SP, von Mehren M, et al. Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules[J]. J Clin Oncol, 2009, 27 (25): 4188-4196.
[17]	Nathan H, Raut CP, Thornton K, et al. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system[J]. Ann Surg, 2009, 250(6): 970-976.
[18]	Sogaard AS, Laurberg JM, Sorensen M, et al. Intraabdominal and retroperitoneal soft-tissue sarcomas--outcome of surgical treatment in primary and recurrent tumors[J]. World J Surg Oncol, 2010, 8(1): 81.
[19]	Strauss DC, Hayes AJ, Thway K, et al. Surgical management of primary retroperitoneal sarcoma[J]. Br J Surg, 2010, 97(5): 698-706.
[20]	Singer S, Alektiar K. Alektiar treatment recommendations for retroperitoneal liposarcoma[J]. Int J Radiat Oncol Biol Phys, 2017, 98(2): 271.
[21]	Gilbeau L, Kantor G, Stoeckle E, et al. Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma[J]. Radiother Oncol, 2002, 65 (3): 137-143.

Please choose a citation manager

Content to export